{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T14:22:24Z","timestamp":1781101344236,"version":"3.54.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>The epidemiologic scenario of prostate cancer (PC) is changing rapidly. The present study updates to 2024 the estimates of PC in Italy, including incident and prevalent cases, deaths, and metastatic PC (mPC), which is further subdivided into de novo mPC (metastasis detected at diagnosis) and recurrent mPC (metachronous metastasis).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The study was based on updated data from the Italian Network of Cancer Registries and the National Institute of Statistics and the age-specific short-term PC projections made available by the International Agency for Cancer Research. For mPC, we applied the age-specific ratios between deaths and estimated de novo and recurrent mPCs for the USA to the Italian age-specific deaths.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In Italy, in 2024, we expect 8400 PC deaths, approximately 39\u2009000 new diagnoses, 4900 of whom are diagnoses of mPC, and almost 670\u2009000 prevalent cases, about 36\u2009000 of whom are mPCs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>These estimates provide updated and realistic information to policy makers, clinicians, and the community to properly address the needs of patients with PC in Italy from diagnosis to end-of-life care.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cej.0000000000000960","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T05:00:20Z","timestamp":1740114020000},"page":"387-391","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["The burden of prostate cancer and metastatic prostate cancer in Italy in 2024"],"prefix":"10.1097","volume":"34","author":[{"given":"Emanuele","family":"Crocetti","sequence":"first","affiliation":[{"name":"Emilia-Romagna Cancer Registry, Romagna Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Ravaioli","sequence":"additional","affiliation":[{"name":"Emilia-Romagna Cancer Registry, Romagna Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Falcini","sequence":"additional","affiliation":[{"name":"Emilia-Romagna Cancer Registry, Romagna Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola"},{"name":"Cancer Prevention Unit, Local Health Authority, Forl\u00ec, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Vattiato","sequence":"additional","affiliation":[{"name":"Emilia-Romagna Cancer Registry, Romagna Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Mancini","sequence":"additional","affiliation":[{"name":"Emilia-Romagna Cancer Registry, Romagna Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Baldacchini","sequence":"additional","affiliation":[{"name":"Emilia-Romagna Cancer Registry, Romagna Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Zamagni","sequence":"additional","affiliation":[{"name":"Emilia-Romagna Cancer Registry, Romagna Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Vitali","sequence":"additional","affiliation":[{"name":"Emilia-Romagna Cancer Registry, Romagna Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Balducci","sequence":"additional","affiliation":[{"name":"Emilia-Romagna Cancer Registry, Romagna Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauro","family":"Bucchi","sequence":"additional","affiliation":[{"name":"Emilia-Romagna Cancer Registry, Romagna Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orietta","family":"Giuliani","sequence":"additional","affiliation":[{"name":"Emilia-Romagna Cancer Registry, Romagna Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"R2-20250731","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1023\/A:1008301516487","article-title":"Has the PSA wave already crashed upon us? Changes in the epidemiology of prostate cancer from 1985 to 1994 in central Italy.","volume":"10","author":"Barchielli","year":"1999","journal-title":"Ann Oncol"},{"key":"R4-20250731","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.canep.2015.12.004","article-title":"Estimates of prostate cancer burden in Italy.","volume":"40","author":"Capocaccia","year":"2016","journal-title":"Cancer Epidemiology"},{"issue":"2 Suppl 1","key":"R5-20250731","first-page":"1","article-title":"Survival of cancer patients in Italy.","volume":"41","author":"Coviello","year":"2017","journal-title":"Epidemiol Prev"},{"key":"R6-20250731","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/0300891618766177","article-title":"Metastatic breast cancers: estimates for Italy.","volume":"104","author":"Crocetti","year":"2018","journal-title":"Tumori"},{"key":"R9-20250731","doi-asserted-by":"crossref","first-page":"1242639","DOI":"10.3389\/fonc.2023.1242639","article-title":"Cohort profile: the Turin prostate cancer prognostication (TPCP) cohort.","volume":"13","author":"Destefanis","year":"2023","journal-title":"Front Oncol"},{"key":"R10-20250731","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1158\/1055-9965.EPI-22-1038","article-title":"Estimating the number of men living with metastatic prostate cancer in the United States.","volume":"32","author":"Devasia","year":"2023","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R13-20250731","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12885-018-4053-y","article-title":"Characteristics of people living in Italy after a cancer diagnosis in 2010 and projections to 2020.","volume":"18","author":"Guzzinati","year":"2018","journal-title":"BMC Cancer"},{"key":"R16-20250731","doi-asserted-by":"crossref","first-page":"e000040","DOI":"10.1136\/esmoopen-2016-000040","article-title":"International survey of androgen deprivation therapy (ADT) for non-metastatic prostate cancer in 19 countries.","volume":"1","author":"Liede","year":"2016","journal-title":"ESMO Open"},{"key":"R17-20250731","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.euros.2023.05.011","article-title":"How to follow the new EU Council recommendation and improve prostate cancer early detection: the Prostaforum 2022 declaration.","volume":"53","author":"M\u00e1jek","year":"2023","journal-title":"Eur Urol Open Sci"},{"key":"R19-20250731","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/UPJ.0000000000000363","article-title":"The cost of metastatic prostate cancer in the United States.","volume":"10","author":"Olsen","year":"2023","journal-title":"Urol Pract"},{"key":"R20-20250731","doi-asserted-by":"crossref","first-page":"e022457","DOI":"10.1136\/bmjopen-2018-022457","article-title":"Lifetime risk of prostate cancer overdiagnosis in Australia: quantifying the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach.","volume":"9","author":"Pathirana","year":"2019","journal-title":"BMJ Open"},{"key":"R21-20250731","doi-asserted-by":"crossref","first-page":"e2337272","DOI":"10.1001\/jamanetworkopen.2023.37272","article-title":"Survival outcomes by race and ethnicity in Veterans with nonmetastatic castration-resistant prostate cancer.","volume":"6","author":"Rasmussen","year":"2023","journal-title":"JAMA Netw Open"},{"key":"R22-20250731","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.urology.2020.11.022","article-title":"Trends for stage and grade group of prostate cancer in the US (2010-2016).","volume":"149","author":"Schmanke","year":"2021","journal-title":"Urology"},{"key":"R24-20250731","first-page":"210","article-title":"Prevalence of prostate cancer at different clinical stages in Italy: estimated burden of disease based on a modelling study.","volume":"10","author":"Spandonaro","year":"2021","journal-title":"Biology (Basel)"},{"key":"R25-20250731","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s10916-023-01991-8","article-title":"Danish Prostate Registry (DanProst): an updated version of the Danish Prostate Cancer Registry, methodology, and early results.","volume":"47","author":"Stroomberg","year":"2023","journal-title":"J Med Syst"},{"key":"R26-20250731","doi-asserted-by":"crossref","first-page":"101833","DOI":"10.1016\/j.canep.2020.101833","article-title":"Epidemiology of metastatic castration-resistant prostate cancer: a first estimate of incidence and prevalence using the French nationwide healthcare database.","volume":"69","author":"Thurin","year":"2020","journal-title":"Cancer Epidemiology"},{"key":"R27-20250731","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejca.2016.07.021","article-title":"Prostate cancer changes in clinical presentation and treatments in two decades: an Italian population-based study.","volume":"67","author":"Trama","year":"2016","journal-title":"Eur J Cancer"},{"key":"R28-20250731","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.eururo.2023.08.002","article-title":"Early detection of prostate cancer in the European Union: combining forces with PRAISE-U.","volume":"84","author":"Van Poppel","year":"2023","journal-title":"Eur Urol"},{"key":"R29-20250731","doi-asserted-by":"crossref","first-page":"292","DOI":"10.5301\/tj.5000613","article-title":"Changes in mortality and incidence of prostate cancer by risk class in different periods in Italy: the possible effects of PSA spread.","volume":"103","author":"Vicentini","year":"2017","journal-title":"Tumori"},{"key":"R30-20250731","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/0284186X.2019.1662084","article-title":"Temporal changes in survival in men with de novo metastatic prostate cancer: nationwide population-based study.","volume":"59","author":"Westerberg","year":"2020","journal-title":"Acta Oncol"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000960","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T13:00:34Z","timestamp":1753966834000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000960","relation":{},"ISSN":["0959-8278","1473-5709"],"issn-type":[{"value":"0959-8278","type":"print"},{"value":"1473-5709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]}}}